Procter & Gamble Company (The) $PG Stock Sold by Payden & Rygel

Payden & Rygel trimmed its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 99.0% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 580 shares of the company’s stock after selling 56,120 shares during the period. Payden & Rygel’s holdings in Procter & Gamble were worth $84,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. BlackRock Inc. bought a new position in Procter & Gamble during the second quarter valued at $27,862,105,000. State Street Corp lifted its position in shares of Procter & Gamble by 1.0% during the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after purchasing an additional 965,461 shares during the last quarter. Bank of America Corp DE purchased a new stake in shares of Procter & Gamble in the second quarter valued at approximately $3,850,628,000. Bank of New York Mellon Corp purchased a new stake in Procter & Gamble in the second quarter worth about $2,281,505,000. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Procter & Gamble by 2.6% during the first quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock valued at $1,704,182,000 after purchasing an additional 300,280 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
• Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
• Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
• Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
• Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe

Analyst Ratings Changes

A number of equities research analysts recently weighed in on PG shares. Argus downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Friday, August 7th. Wells Fargo & Company boosted their price target on Procter & Gamble from $164.00 to $180.00 and gave the stock an “overweight” rating in a research note on Friday, October 23rd. Citigroup upped their price objective on shares of Procter & Gamble from $180.00 to $187.00 and gave the company a “buy” rating in a report on Friday, October 23rd. TD Cowen increased their price objective on shares of Procter & Gamble from $150.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, October 23rd. Finally, DZ Bank cut shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Fifteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $170.57.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Shailesh Jejurikar sold 35,000 shares of the firm’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the transaction, the chief executive officer owned 55,391 shares of the company’s stock, valued at $9,033,718.19. This trade represents a 38.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 4,181 shares of the business’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $160.71, for a total transaction of $671,928.51. Following the transaction, the insider owned 11,296 shares of the company’s stock, valued at $1,815,380.16. This represents a 27.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 58,647 shares of company stock worth $9,268,508. Corporate insiders own 0.23% of the company’s stock.

Procter & Gamble Trading Up 0.5%

Shares of NYSE:PG opened at $161.42 on Friday. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The stock has a market cap of $374.14 billion, a price-to-earnings ratio of 24.31, a PEG ratio of 3.95 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. The business has a 50-day moving average price of $149.99 and a 200-day moving average price of $148.94.

Procter & Gamble (NYSE:PG) last issued its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. During the same quarter in the prior year, the firm earned $1.99 earnings per share. Procter & Gamble’s revenue for the quarter was up 4.0% on a year-over-year basis. Equities analysts predict that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s payout ratio is presently 65.51%.

Procter & Gamble Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.